Identification of Prognostic Biomarker Candidates Associated With Melanoma Using High-Dimensional Genomic Data

Survival of patients with metastatic melanoma varies widely. Melanoma is a highly proliferative, chemo-resistant disease. With the recent availability of immunotherapies such as checkpoint inhibitors, durable response rates have improved but are often still limited to 2–3 years. Response rates to tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutt, Brody, Burdorf, Rachel, Bain, Travaughn, Cameron, Nicardo, Pearah, Alexia, Subasi, Ersoy, Carroll, David J., Moore, Lisa K., Subasi, Munevver Mine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473904/
https://www.ncbi.nlm.nih.gov/pubmed/34589115
http://dx.doi.org/10.3389/fgene.2021.707105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473904/
https://www.ncbi.nlm.nih.gov/pubmed/34589115
http://dx.doi.org/10.3389/fgene.2021.707105

Ejemplares similares